EXHIBIT 23.2
Published on March 24, 2009
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statement of
Rexahn Pharmaceuticals, Inc. on Form S-8 (Registration Statement No.
333-129294) and the Registration Statement of Rexahn Pharmaceuticals, Inc. on
Form S-3 (Registration Statement No. 333-152640) of our report dated March 24,
2008 (which report expresses an unqualified opinion), relating to the financial
statements of Rexahn Pharmaceuticals, Inc. included in this Annual Report on
Form 10-K of Rexahn Pharmaceuticals, Inc. for the year ended
December 31, 2008.
/s/ Lazar, Levine &
Felix LLP
New York,
New York
March 24,
2009